Items where authors include "Kershaw, S"
Up a levelArticle
Ahmed, WUR, Bhatia, S, McLean, KA et al. (4545 more authors) (2022) Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery. BJS Open, 6 (1). zrab150. ISSN 2474-9842
Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736
Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736
Kershaw, S, Morgan, DJ, Boyd, J et al. (11 more authors) (2020) Glucocorticoids rapidly inhibit cell migration through a novel, non-transcriptional HDAC6 pathway. Journal of Cell Science, 133 (11). 242842. ISSN 0021-9533
Caratti, G, Matthews, L, Poolman, T et al. (3 more authors) (2015) Glucocorticoid receptor function in health and disease. Clinical Endocrinology, 83 (4). pp. 441-448. ISSN 0300-0664
Proceedings Paper
Leslie, F, Kershaw, S, Pfänder, P et al. (6 more authors) (2019) Global phosphoproteomics links rapidly induced cytoplasmic signals to transcriptional control. In: Endocrine Abstracts (2019). Society for Endocrinology BES 2019, 11-13 Nov 2019, Brighton, UK. Society for Endocrinology .
Kershaw, S, Morgan, D, Boyd, J et al. (6 more authors) (2017) Glucocorticoids rapidly inhibit cell migration through a novel, non-transcriptional pathway involving HDAC6. In: Endocrine Abstracts (2017). Society for Endocrinology BES 2017, 06-08 Nov 2017, Harrogate, UK. Society for Endocrinology .
Kershaw, S, Morgan, D, Poolman, T et al. (3 more authors) (2015) Glucocorticoids stabilise the microtubule network to inhibit cell migration. In: Endocrine Abstracts. Society for Endocrinology BES 2015, 02-04 Nov 2015, Edinburgh, UK. .